Citation: H. Beving et al., ABNORMALLY HIGH PLATELET ACTIVITY AFTER DISCONTINUATION OF ACETYLSALICYLIC-ACID TREATMENT, Blood coagulation & fibrinolysis, 7(1), 1996, pp. 80-84
Authors:
FATAH K
BEVING H
ALBAGE A
IVERT T
BLOMBACK M
Citation: K. Fatah et al., ACETYLSALICYLIC-ACID MAY PROTECT THE PATIENT BY INCREASING FIBRIN GELPOROSITY - IS WITHDRAWING OF TREATMENT HARMFUL TO THE PATIENT, European heart journal, 17(9), 1996, pp. 1362-1366
Authors:
FATAH K
BEVING H
ALBAGE A
IVER T
BLOMBACK M
Citation: K. Fatah et al., ACETYLSALICYLIC-ACID MAY PROTECT THE PATIENT BY INCREASING FIBRIN GELPOROSITY - DANGER OF WITHDRAWING TREATMENT, Thrombosis and haemostasis, 73(6), 1995, pp. 1228-1228
Citation: H. Beving et al., DIELECTRIC-PROPERTIES OF HUMAN BLOOD AND ERYTHROCYTES AT RADIO FREQUENCIES (0.2-10-MHZ) - DEPENDENCE ON CELL-VOLUME FRACTION AND MEDIUM COMPOSITION, European biophysics journal, 23(3), 1994, pp. 207-215
Authors:
BEVING H
EKSBORG S
MALMGREN RS
NORDLANDER R
RYDEN L
OLSSON P
Citation: H. Beving et al., INTERINDIVIDUAL VARIATIONS OF THE EFFECT OF LOW-DOSE ASPIRIN REGIME ON PLATELET CYCLOOXYGENASE ACTIVITY, Thrombosis research, 74(1), 1994, pp. 39-51
Citation: Leg. Eriksson et H. Beving, CALCIUM-ACTIVATED AND LEAD-ACTIVATED MORPHOLOGICAL-CHANGES IN HUMAN ERYTHROCYTES - A SPIN-LABEL STUDY OF THE CYTOPLASM, Archives of biochemistry and biophysics, 303(2), 1993, pp. 296-301